Merge PACS vs AVIEW
AI Verdict
Choose Merge PACS if…
Choose Merge PACS if your health system requires an enterprise-level solution to consolidate imaging data across multiple sites and specialties, offering flexible deployment options. It is ideal for organizations seeking a robust PACS that can integrate various third-party AI applications into a single, customizable worklist to enhance diagnostic workflows across the entire enterprise.
View Merge PACS →Choose AVIEW if…
Choose AVIEW if your primary need is a highly specialized AI platform for the precise detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans. This tool is best suited for radiology departments and pulmonology/cardiology specialists who require advanced AI-driven quantification, 3D visualizations, and automated reporting for these specific conditions.
View AVIEW →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Merge PACS | AVIEW |
|---|---|---|
| Pricing | Contact vendor | Subscription; one-off payment |
| Deployment | Cloud-based | Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker) |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Merge PACSMerge PACS offers a highly customizable and intuitive PACS environment with an excellent worklist configuration, as noted by user feedback. Recent usability-oriented improvements, including dynamic worklist refresh and enhanced ROI tooling, further reduce friction during interpretation. While AVIEW provides 3D visualizations and automated reports, Merge PACS's broader focus on a responsive and clinically intuitive viewer for enterprise-wide standardization gives it an edge in overall usability.
Clinical Value
AVIEWAVIEW demonstrates superior direct clinical value through its specialized AI algorithms for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification. Clinical studies have shown AVIEW LCS to have a lower likelihood of misidentifying nodules compared to human radiologists. While Merge PACS provides a robust platform for AI integration, AVIEW offers specific, AI-driven diagnostic aid with proven clinical outcomes for critical conditions.
Pricing & Value
AVIEWAVIEW offers greater transparency in its pricing model, specifying both subscription and one-off payment options based on the number of installations and users. In contrast, Merge PACS requires direct vendor contact for any pricing details, making it less transparent for initial evaluation of value.
Enterprise Readiness
Merge PACSMerge PACS is explicitly designed as an 'enterprise-level PACS' for 'multi-site health systems,' offering a holistic ecosystem for cardiology, radiology, and enterprise imaging. It provides extensive integration capabilities with EMR/EHR, RIS, HIS, and VNA systems, and flexible deployment options. While AVIEW also supports multi-center operations and flexible deployment, Merge PACS's core offering and established presence as an enterprise imaging solution provide a more comprehensive enterprise readiness.
Innovation
AVIEWAVIEW showcases greater innovation by developing and applying proprietary deep learning AI algorithms for direct, automated diagnostic analysis of specific diseases like lung cancer, COPD, and coronary artery calcification. Its AVIEW 2.0 system integrates these quantifications into a single analytical pipeline. Merge PACS, while innovative as an 'AI ready' platform for integrating third-party AI, focuses more on workflow enhancement rather than proprietary AI diagnostic development.
Support & Docs
Merge PACSMerge PACS offers more comprehensive and transparent support and documentation resources, including a user community, multiple direct contact channels (phone, email), and readily available product documentation such as user manuals and DICOM conformance statements. AVIEW primarily highlights its research publications and output reports, but lacks explicit details on dedicated customer support channels or extensive product documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Merge PACS | AVIEW |
|---|---|---|
| Primary Specialties | Cardiology, Radiology | Cardiology, Pulmonology, Radiology |
| Core AI Applications | AI integration and readiness (single worklist access to 3rd party AI applications), customizable composite worklist, enhanced diagnostic workflows (e.g., Synchronized Priors Scrolling, image fusion), real-time analytics and dashboards | AI-powered lung nodule detection and characterization, emphysema quantification, coronary artery calcium (CAC) scoring, automated segmentation, 3D visualizations, ILD pattern analysis |
| Workflow Integration | Integration with EMR/EHR, RIS, HIS, and VNA systems | Workflow automation and integration with PACS/RIS/CIS |
| Enterprise Image Management | Enterprise-wide image management and consolidation | Not specified |
| Remote Access | Secure web-based access for remote reading | Not specified |
Videos
Demos, reviews, and walkthroughs featuring Merge PACS and AVIEW.